Works matching IS 03407004 AND DT 2020 AND VI 69 AND IP 11
Results: 21
Immune resilience in response to cancer therapy.
- Published in:
- 2020
- By:
- Publication type:
- Editorial
Silent acute appendicitis revealed by PET-CT during treatment with ipilimumab and nivolumab: a new immune-related adverse event.
- Published in:
- 2020
- By:
- Publication type:
- Letter
Brief report: inhaled corticosteroid use and the risk of checkpoint inhibitor pneumonitis in patients with advanced cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2403, doi. 10.1007/s00262-020-02674-w
- By:
- Publication type:
- Article
Augmenting engineered T-cell strategies in solid cancers through epigenetic priming.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2169, doi. 10.1007/s00262-020-02661-1
- By:
- Publication type:
- Article
Clinicopathological factors associated with tumor-infiltrating lymphocyte reactivity in breast cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2381, doi. 10.1007/s00262-020-02633-5
- By:
- Publication type:
- Article
IL-6-induced CD39 expression on tumor-infiltrating NK cells predicts poor prognosis in esophageal squamous cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2371, doi. 10.1007/s00262-020-02629-1
- By:
- Publication type:
- Article
ADRB3 expression in tumor cells is a poor prognostic factor and promotes proliferation in non-small cell lung carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2345, doi. 10.1007/s00262-020-02627-3
- By:
- Publication type:
- Article
Micro-environmental cross-talk in an organotypic human melanoma-in-skin model directs M2-like monocyte differentiation via IL-10.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2319, doi. 10.1007/s00262-020-02626-4
- By:
- Publication type:
- Article
Phase I trial evaluating safety and efficacy of intratumorally administered inflammatory allogeneic dendritic cells (ilixadencel) in advanced gastrointestinal stromal tumors.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2393, doi. 10.1007/s00262-020-02625-5
- By:
- Publication type:
- Article
Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2291, doi. 10.1007/s00262-020-02624-6
- By:
- Publication type:
- Article
Differences in the sensitivity of classically and alternatively activated macrophages to TAK1 inhibitor-induced necroptosis.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2193, doi. 10.1007/s00262-020-02623-7
- By:
- Publication type:
- Article
Metabolomic profiling of tumor-infiltrating macrophages during tumor growth.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2357, doi. 10.1007/s00262-020-02622-8
- By:
- Publication type:
- Article
Infiltration of T cells promotes the metastasis of ovarian cancer cells via the modulation of metastasis-related genes and PD-L1 expression.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2275, doi. 10.1007/s00262-020-02621-9
- By:
- Publication type:
- Article
Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2233, doi. 10.1007/s00262-020-02620-w
- By:
- Publication type:
- Article
Exploratory open-label clinical study to determine the S-588410 cancer peptide vaccine-induced tumor-infiltrating lymphocytes and changes in the tumor microenvironment in esophageal cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2247, doi. 10.1007/s00262-020-02619-3
- By:
- Publication type:
- Article
Differences in PD-1 expression on CD8+ T-cells in chronic myeloid leukemia patients according to disease phase and TKI medication.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2223, doi. 10.1007/s00262-020-02617-5
- By:
- Publication type:
- Article
Clinicopathologic correlates of first-line pembrolizumab effectiveness in patients with advanced NSCLC and a PD-L1 expression of ≥ 50%.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2209, doi. 10.1007/s00262-020-02613-9
- By:
- Publication type:
- Article
Cell composition and expansion strategy can reduce the beneficial effect of AKT-inhibition on functionality of CD8<sup>+</sup> T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2259, doi. 10.1007/s00262-020-02612-w
- By:
- Publication type:
- Article
Combination of cyclin-dependent kinase and immune checkpoint inhibitors for the treatment of bladder cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2305, doi. 10.1007/s00262-020-02609-5
- By:
- Publication type:
- Article
CD200 is overexpressed in neuroblastoma and regulates tumor immune microenvironment.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2333, doi. 10.1007/s00262-020-02589-6
- By:
- Publication type:
- Article
In vitro 4-1BB stimulation promotes expansion of CD8<sup>+</sup> tumor-infiltrating lymphocytes from various sarcoma subtypes.
- Published in:
- Cancer Immunology, Immunotherapy, 2020, v. 69, n. 11, p. 2179, doi. 10.1007/s00262-020-02568-x
- By:
- Publication type:
- Article